Shorepoint Capital Partners LLC Novartis Ag Transaction History

Shorepoint Capital Partners LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$82.14 - $91.0 $1.8 Million - $2 Million	-21,926 Closed	0 $0
Q2 2020 Aug 12, 2020	SELL	$80.93 - $91.1 $239,957 - $270,111	-2,965 Reduced 11.91%	21,926 $1.92 Million
Q1 2020 May 14, 2020	BUY	$70.67 - $99.01 $9,116 - $12,772	129 Added 0.52%	24,891 $2.05 Million
Q4 2019 Feb 14, 2020	SELL	$84.35 - $95.37 $99,786 - $112,822	-1,183 Reduced 4.56%	24,762 $2.35 Million
Q3 2019 Nov 14, 2019	SELL	$85.54 - $94.26 $118,729 - $130,832	-1,388 Reduced 5.08%	25,945 $2.26 Million
Q2 2019 Aug 14, 2019	BUY	$75.4 - $92.8 $49,010 - $60,320	650 Added 2.44%	27,333 $2.5 Million
Q1 2019 Apr 12, 2019	BUY	$75.32 - $86.15 $2.01 Million - $2.3 Million	26,683 New	26,683 $2.57 Million

1,437

131M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $209B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Shorepoint Capital Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Shorepoint Capital Partners LLC with notifications on news.